Nakamura Takamitsu, Kugiyama Kiyotaka
Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Nakakoma-gun, Yamanashi 409-3898, Japan.
Curr Atheroscler Rep. 2006 Mar;8(2):107-10. doi: 10.1007/s11883-006-0047-3.
Coronary artery disease (CAD) is the largest cause of morbidity and mortality in the world. A relationship between CAD and elevated levels of low-density lipoprotein cholesterol has been established. However, risk assessment limited to low-density lipoprotein fails to identify a significant portion of patients at risk for CAD. Remnant lipoproteins, derived from very low-density lipoprotein and chylomicrons, have been considered atherogenic. Recently, a simple and reliable immunoaffinity separation method for the isolation of remnant-like particles (RLP) has been developed. It has been shown that RLP cholesterol levels are significantly correlated with CAD, and thus cellular mechanisms have been determined by which RLP cholesterol causes progression of atherosclerosis. Measurement of RLP cholesterol is useful for the assessment of risk and the evaluation of therapy in patients at risk for CAD.
冠状动脉疾病(CAD)是全球发病和死亡的主要原因。CAD与低密度脂蛋白胆固醇水平升高之间的关系已被确立。然而,仅局限于低密度脂蛋白的风险评估无法识别出很大一部分有CAD风险的患者。源自极低密度脂蛋白和乳糜微粒的残余脂蛋白被认为具有致动脉粥样硬化作用。最近,一种用于分离残余样颗粒(RLP)的简单可靠的免疫亲和分离方法已被开发出来。研究表明,RLP胆固醇水平与CAD显著相关,因此已经确定了RLP胆固醇导致动脉粥样硬化进展的细胞机制。测量RLP胆固醇对于评估CAD风险患者的风险及治疗效果很有用。